Research location

Xianyang

Shaanxi, China

Published trials19
Site observations20
Linked trials published19
Page1 / 1
Advertisement

Research activity in Xianyang

Shaanxi, China

CureCurrent currently publishes aggregate city-level research activity for this location: 19 trials and 20 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Xianyang

19 linked trials · page 1 of 1
A Study to Evaluate the Effects of Enicepatide in Participants With Obesity or Overweight, With or Without Type 2 DiabetesNCT07670416 · 2026-07-03 · 1 site observation
RECRUITING
Qishen Yiqi Dripping Pills in Treatment of Chronic Heart FailUreNCT07687186 · 2026-06-22 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 DiabetesNCT07351058 · 2026-03-23 · 1 site observation
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 DiabetesNCT07351045 · 2026-03-16 · 1 site observation
RECRUITING
Plasma Exosomal RNA Signature for Prostate Cancer Bone MetastasisNCT07553754 · 2026-03-12 · 1 site observation
RECRUITING
A Multicenter, Prospective Study on the Prognostic Value of PSMA PET in Patients With Newly Diagnosed, Treatment-naïve Prostate CancerNCT07474142 · 2026-03-03 · 1 site observation
RECRUITING
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisNCT07225504 · 2025-11-11 · 1 site observation
RECRUITING
Plasma exoRNA-Based Liquid Biopsy to Diagnose Clinically Significant Prostate CancerNCT07492927 · 2021-03-12 · 1 site observation
RECRUITING
Serial PSMA PET for Therapy Monitoring in Clinically Significant Prostate CancerNCT07553780 · 2021-03-07 · 1 site observation
RECRUITING
Delayed PSMA PET/CT Imaging for Diagnosing Clinically Significant Prostate Cancer in Biopsy-Naïve Men With Suspected Prostate CancerNCT07531329 · 2021-03-05 · 1 site observation
RECRUITING
A Multicenter Study on the Normal Reference Range and Clinical Significance of the Right Atrioventricular Coupling Index Assessed by Artificial Intelligence-Based Three-Dimensional EchocardiographyNCT07292896 · 2025-12-01 · 1 site observation
NOT_YET_RECRUITING
Efficacy and Safety of CP006 Inhalation Powder in Participants With AsthmaNCT07807007 · 2025-11-21 · 1 site observation
COMPLETED
Evaluation of the Clinical Trial of Inhaled TQC3721 Suspension in Patients With Moderate-to-Severe Chronic Obstructive Pulmonary DiseaseNCT07147946 · 2025-09-01 · 1 site observation
NOT_YET_RECRUITING
Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 DiabetesNCT06350890 · 2023-11-05 · 1 site observation
COMPLETED
Plasma Exosome RNA to Diagnose Prostate CancerNCT06604130 · 2021-03-12 · 1 site observation
ENROLLING_BY_INVITATION
A Research Study, Looking at How Tresiba® Works in People With Type 2 Diabetes in Local Clinical Practice in ChinaNCT04227431 · 2020-01-17 · 1 site observation
COMPLETED
Survival Study of the Recombinant Human Neuregulin-1β in Subjects With Chronic Heart Failure.NCT03388593 · 2018-07-23 · 1 site observation
UNKNOWN
Controlling Hypertension After Severe Cerebrovascular EventNCT02982655 · 2017-01-01 · 2 site observations
COMPLETED
Clinical Assessment of Complementary Treatment With Qishen Yiqi Dripping Pills on Ischemic Heart FailureNCT01555320 · 2012-03-01 · 1 site observation
UNKNOWN
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.